| Big Horn Basin Counseling Services | |
|
116 South 3rd Basin WY 82410 | |
| (307) 568-2020 | |
| (307) 568-2503 |
| Full Name | Big Horn Basin Counseling Services |
|---|---|
| Speciality | Clinic/center - Mental Health (including Community Mental Health Center) |
| Location | 116 South 3rd, Basin, Wyoming |
| Authorized Official Name and Position | Autumn Marie Snyder (ADMINISTRATIVE ASSISTANT) |
| Authorized Official Contact | 3075486543 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Big Horn Basin Counseling Services 1114 Lane 12 Lovell WY 82431-9555 Ph: (307) 548-6543 | Big Horn Basin Counseling Services 116 South 3rd Basin WY 82410 Ph: (307) 568-2020 |
| NPI Number | 1144373440 |
|---|---|
| Provider Enumeration Date | 01/19/2007 |
| Last Update Date | 10/29/2015 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144373440 | NPI | - | NPPES |
| 106515702 | Medicaid | WY | |
| 106515705 | Medicaid | WY | |
| 106515706 | Medicaid | WY | |
| 106515703 | Medicaid | WY | |
| 106515700 | Medicaid | WY | |
| 106515701 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (Wyoming) | Primary |
News Archive
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Optimal IMX continued to build on its industry leading radiology services business by selecting and implementing MobileMD's Health Information Exchange (HIE) technologies and services. Optimal uses MobileMD's turnkey technology and services to establish HIT connectivity and interoperability with their client facilities and physician community.
Doctors save lives, but they can sometimes be insufferable know-it-alls who bully nurses and do not listen to patients. Medical schools have traditionally done little to screen out such flawed applicants or to train them to behave better, but that is changing.
AMAG Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today provided a regulatory and clinical update for Feraheme® (ferumoxytol) Injection for intravenous (IV) use.
› Verified 1 days ago